and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  H. Gabius,et al.  Comparative cross-linking activities of lactose-specific plant and animal lectins and a natural lactose-binding immunoglobulin G fraction from human serum with asialofetuin. , 1996, Glycobiology.

[3]  Lin Chen,et al.  Transcriptional Regulation ofN-Acetylglucosaminyltransferase V by the srcOncogene* , 1997, The Journal of Biological Chemistry.

[4]  Zhichao Pei,et al.  Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. , 2006, Bioorganic & medicinal chemistry.

[5]  K. Segawa,et al.  Increased expression of highly branched N-glycans at cell surface is correlated with the malignant phenotypes of mouse tumor cells. , 1997, Cancer research.

[6]  R. Kiss,et al.  Evidence for Stimulation of Tumor Proliferation in Cell Lines and Histotypic Cultures by Clinically Relevant Low Doses of the Galactoside-Binding Mistletoe Lectin, A Component of Proprietary Extracts , 2001, Cancer investigation.

[7]  A. M. Wu,et al.  Carbohydrate specificity of a galectin from chicken liver (CG-16). , 2001, The Biochemical journal.

[8]  J. Marth,et al.  A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.

[9]  A. Soza,et al.  Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells. , 2006, Experimental cell research.

[10]  S. C. Hubbard,et al.  Differential effects of oncogenic transformation on N-linked oligosaccharide processing at individual glycosylation sites of viral glycoproteins. , 1987, The Journal of biological chemistry.

[11]  J. Bolscher,et al.  Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene. , 1991, The Journal of biological chemistry.

[12]  S. Bellis,et al.  Ras oncogene directs expression of a differentially sialylated, functionally altered β1 integrin , 2003, Oncogene.

[13]  S. Yamamoto,et al.  Structures of the Sugar Chains of Interferon- γ Produced by Human Myelomonocyte Cell Line HBL-38 , 1989 .

[14]  M. Glick,et al.  Malignant cell glycoproteins and glycolipids. , 1989, Critical reviews in oncology/hematology.

[15]  H Kaltner,et al.  Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3* , 2001, The Journal of Biological Chemistry.

[16]  M. Molinari,et al.  The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. , 2005, Trends in cell biology.

[17]  H. Gabius,et al.  Eukaryotic glycosylation: whim of nature or multipurpose tool? , 1999, Cellular and Molecular Life Sciences CMLS.

[18]  P. Lance,et al.  Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. , 2001, Biochimica et biophysica acta.

[19]  A. Heck,et al.  Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells , 2003, Oncogene.

[20]  R. Lotan,et al.  Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1. , 1999, International journal of oncology.

[21]  K. Kayser,et al.  Galectins-1 and -3 and their ligands in tumor biology , 1999, Journal of Cancer Research and Clinical Oncology.

[22]  Albert J R Heck,et al.  Carbohydrate chain of ganglioside GM1 as a ligand: identification of the binding strategies of three 15 mer peptides and their divergence from the binding modes of growth-regulatory galectin-1 and cholera toxin. , 2005, Chemistry.

[23]  Si Zhang,et al.  β1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma* , 2006, Journal of Biological Chemistry.

[24]  H. Gabius,et al.  Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries. , 2007, Bioorganic & medicinal chemistry letters.

[25]  M. Kaplan,et al.  Cutting Edge: Differential Requirements for Stat4 in Expression of Glycosyltransferases Responsible for Selectin Ligand Formation in Th1 Cells1 , 2001, The Journal of Immunology.

[26]  Y. Ikeda,et al.  Regulation of the GnT-V Promoter by Transcription Factor Ets-1 in Various Cancer Cell Lines* , 1999, The Journal of Biological Chemistry.

[27]  Fu-Tong Liu,et al.  Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3, and -7: Evidence for differential binding specificities , 2002 .

[28]  Sheng Pan,et al.  Gene Expression and Proteomic Analysis of Pancreatic Cancer: a Recent Update. , 2006, Cancer genomics & proteomics.

[29]  N. Sharon,et al.  Glycoproteins: Structure and Function , 2008 .

[30]  K. Katagiri,et al.  Occurrence of Oligosialic Acids on Integrin α5Subunit and Their Involvement in Cell Adhesion to Fibronectin* , 2001, The Journal of Biological Chemistry.

[31]  H. Gabius,et al.  First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. , 2003, Organic & biomolecular chemistry.

[32]  K. Yamada,et al.  Analysis of the role of glycosylation of the human fibronectin receptor. , 1989, The Journal of biological chemistry.

[33]  M. Pierce,et al.  Deletion of Mouse Embryo Fibroblast N-Acetylglucosaminyltransferase V Stimulates α5β1 Integrin Expression Mediated by the Protein Kinase C Signaling Pathway* , 2005, Journal of Biological Chemistry.

[34]  S. Akiyama,et al.  Aberrant N-Glycosylation of β1 Integrin Causes Reduced α5β1 Integrin Clustering and Stimulates Cell Migration , 2002 .

[35]  L. Baum,et al.  The ST6Gal I Sialyltransferase Selectively ModifiesN-Glycans on CD45 to Negatively Regulate Galectin-1-induced CD45 Clustering, Phosphatase Modulation, and T Cell Death* , 2003, The Journal of Biological Chemistry.

[36]  Y. Iwakura,et al.  Polylactosamine synthesis and branch formation of N-glycans in beta1,4-galactosyltransferase-1-deficient mice. , 2004, Archives of biochemistry and biophysics.

[37]  J. Gu,et al.  Down-regulation of beta1,4-galactosyltransferase gene expression by cell-cycle suppressor gene p16. , 1999, Biochimica et biophysica acta.

[38]  J. Wakefield,et al.  Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. , 2005, Cancer research.

[39]  F. Poirier,et al.  Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36 , 2001, Cancer Cell International.

[40]  R. Oriol,et al.  Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. , 2005, Blood.

[41]  Hisashi Narimatsu,et al.  A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. , 2006, Glycobiology.

[42]  P. Schlag,et al.  Cell surface α2,6-sialylation affects adhesion of breast carcinoma cells , 2002 .

[43]  T. Habuchi,et al.  N-Acetylglucosaminyltransferase V and β1-6 Branching N-Linked Oligosaccharides Are Associated with Good Prognosis of Patients with Bladder Cancer , 2006, Clinical Cancer Research.

[44]  J. Jiménez-Barbero,et al.  Chemical Biology of the Sugar Code , 2004, Chembiochem : a European journal of chemical biology.

[45]  Lin Chen,et al.  The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products , 1998, Oncogene.

[46]  K. Furukawa,et al.  Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1. , 2004, The Journal of biological chemistry.

[47]  N. Bovin,et al.  α2,3/α2,6-Sialylation of N-glycans: non-synonymous signals with marked developmental regulation in bovine reproductive tracts , 2006 .

[48]  Kwang-Soo Kim,et al.  Gene expression profiling of mouse postnatal cerebellar development using oligonucleotide microarrays designed to detect differences in glycoconjugate expression. , 2005, Gene expression patterns : GEP.

[49]  A. Paller,et al.  Carbohydrate-Carbohydrate Binding of Ganglioside to Integrin α5 Modulates α5β1Function* , 2001, The Journal of Biological Chemistry.

[50]  Hans-Joachim Gabius,et al.  Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation. , 2006, Glycobiology.

[51]  H. Gabius,et al.  Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes* , 2004, Journal of Biological Chemistry.

[52]  N. Taniguchi,et al.  A secreted type of beta 1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity. , 2002, The Journal of biological chemistry.

[53]  Naoyuki Taniguchi,et al.  Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer. , 2006, Biochemical and biophysical research communications.

[54]  S. Hakomori,et al.  Detailed Oligosaccharide Structures of Human Integrin α5β1 Analyzed by a Three‐Dimensional Mapping Technique , 1996 .

[55]  H. Gabius,et al.  Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. , 2004, Bioconjugate chemistry.

[56]  D. A. O’Brien,et al.  Germ Cell Survival Through Carbohydrate-Mediated Interaction with Sertoli Cells , 2002, Science.

[57]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.

[58]  S. Hakomori,et al.  Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. , 1994, The Journal of biological chemistry.

[59]  R. Brossmer,et al.  Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells , 2005, Glycoconjugate Journal.

[60]  H. Gabius,et al.  Branching mode in complex-type triantennary N-glycans as regulatory element of their ligand properties. , 2006, Biochimica et Biophysica Acta.

[61]  D. Vestweber,et al.  Leukocyte Adhesion Deficiency II: Therapy and Genetic Defect , 2002, Cells Tissues Organs.

[62]  H. Gabius,et al.  Introduction of extended LEC14‐type branching into core‐fucosylated biantennary N‐glycan , 2005, The FEBS journal.

[63]  Jesús Jiménez-Barbero,et al.  Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. , 2003, Biochemistry.

[64]  Z. Niu,et al.  Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator. , 2005, The Journal of biological chemistry.

[65]  H. Gabius,et al.  Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody , 2004, Histochemistry.

[66]  D. H. van den Eijnden,et al.  The acceptor substrate specificity of human β4‐galactosyltransferase V indicates its potential function in O‐glycosylation , 1999, FEBS letters.

[67]  Hans-Joachim Gabius,et al.  Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. , 2004, Journal of molecular biology.

[68]  B. Rotblat,et al.  Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. , 2004, Cancer research.

[69]  F. Real,et al.  GalNAc-α-O-benzyl Inhibits NeuAcα2-3 Glycosylation and Blocks the Intracellular Transport of Apical Glycoproteins and Mucus in Differentiated HT-29 Cells , 1998, The Journal of cell biology.

[70]  K. Kumamoto,et al.  Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers , 2004, Cancer Research.

[71]  K. Kayser,et al.  Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. , 2004, European journal of biochemistry.

[72]  O Hindsgaul,et al.  Synthesis of Poly-N-acetyllactosamine in Core 2 Branched O-Glycans , 1998, The Journal of Biological Chemistry.

[73]  G. Sundblad,et al.  Mitogenic leukoagglutinin from Phaseolus vulgaris binds to a pentasaccharide unit in N-acetyllactosamine-type glycoprotein glycans. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Hiroko Ito,et al.  Rapid cell senescence-associated changes in galactosylation of N-linked oligosaccharides in human lung adenocarcinoma A549 cells. , 2004, Archives of biochemistry and biophysics.

[75]  R. Kannagi,et al.  Significance of 2‐3 and 2‐6 sialylation of Lewis A antigen in pancreas cancer , 1988, Cancer.

[76]  D. G. Zisoulis,et al.  A crucial role for T-bet in selectin ligand expression in T helper 1 (Th1) cells. , 2005, Blood.

[77]  J. Baenziger,et al.  Oligosaccharide specificities of Phaseolus vulgaris leukoagglutinating and erythroagglutinating phytohemagglutinins. Interactions with N-glycanase-released oligosaccharides. , 1987, The Journal of biological chemistry.

[78]  J. Gu,et al.  High expression of N‐acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis , 2006, FEBS letters.

[79]  J. Moskal,et al.  Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo. , 2001, Cancer research.

[80]  M. Vidal,et al.  Unique sequence and expression profiles of rat galectins-5 and -9 as a result of species-specific gene divergence. , 2006, The international journal of biochemistry & cell biology.

[81]  H. Gabius,et al.  Plant lectins: Occurrence, biochemistry, functions and applications , 2001, Glycoconjugate Journal.

[82]  T. Sakai,et al.  Galectin-1 Interacts with the α5β1 Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27* , 2005, Journal of Biological Chemistry.

[83]  E. Berger,et al.  Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. , 2002, The Journal of clinical investigation.

[84]  Albert J R Heck,et al.  Determination of structural and functional overlap/divergence of five proto‐type galectins by analysis of the growth‐regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells , 2005, International journal of cancer.

[85]  B. Wiedenmann,et al.  A Novel Function for the Tumor Suppressor p16INK4a , 2000, The Journal of Cell Biology.

[86]  Ying Zhang,et al.  Regulation on the expression and N-glycosylation of integrins by N-acetylglucosaminyltransferase V. , 2003, Biochemical and biophysical research communications.

[87]  S. Stowell,et al.  Dimeric Galectin-1 Binds with High Affinity to α2,3-Sialylated and Non-sialylated Terminal N-Acetyllactosamine Units on Surface-bound Extended Glycans* , 2005, Journal of Biological Chemistry.

[88]  C. Chen,et al.  Down-regulation of the expression of β1,4-galactosyltransferase V promotes integrin β1 maturation , 2006 .

[89]  H. Gabius,et al.  Glycohistochemistry: The Why and How of Detection and Localization of Endogenous Lectins , 2001, Anatomia, histologia, embryologia.

[90]  B. Wiedenmann,et al.  Human Galectin-2: Novel Inducer of T Cell Apoptosis with Distinct Profile of Caspase Activation1 , 2004, The Journal of Immunology.

[91]  M. Engelse,et al.  Activation of human endothelial cells by tumor necrosis factor‐α results in profound changes in the expression of glycosylation‐related genes , 2006, Journal of cellular physiology.

[92]  Fu-Tong Liu,et al.  New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites , 2003, Biology of the cell.

[93]  E. Eklund,et al.  Hyposialylation of Integrins Stimulates the Activity of Myeloid Fibronectin Receptors* , 2002, The Journal of Biological Chemistry.

[94]  A. Kobata,et al.  Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. , 1984, The Journal of biological chemistry.

[95]  I. Brockhausen,et al.  Mucin synthesis. Conversion of R1-beta 1-3Gal-R2 to R1-beta 1-3(GlcNAc beta 1-6)Gal-R2 and of R1-beta 1-3GalNAc-R2 to R1-beta 1-3(GlcNAc beta 1-6)GalNAc-R2 by a beta 6-N-acetylglucosaminyltransferase in pig gastric mucosa. , 1986, European journal of biochemistry.

[96]  Y. Arata,et al.  Analyses of N-linked oligosaccharides using a two-dimensional mapping technique. , 1988, Analytical biochemistry.

[97]  J. Arango,et al.  Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. , 1986, The Journal of biological chemistry.

[98]  M. Dalziel,et al.  Ras oncogene induces β‐galactoside α2,6‐sialyltransferase (ST6Gal I) via a RalGEF‐mediated signal to its housekeeping promoter , 2004 .

[99]  H. Gabius,et al.  The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acidα2,6GalNAc , 2005 .

[100]  Hans-Joachim Gabius,et al.  Galectin-1 Is a Major Receptor for Ganglioside GM1, a Product of the Growth-controlling Activity of a Cell Surface Ganglioside Sialidase, on Human Neuroblastoma Cells in Culture* , 1998, The Journal of Biological Chemistry.

[101]  J. Moskal,et al.  Transfection of 2,6 and 2,3‐sialyltransferase genes and GlcNAc‐transferase genes into human glioma cell line U‐373 MG affects glycoconjugate expression and enhances cell death , 2004, Journal of neurochemistry.

[102]  H. Gabius.  Influence of type of linkage and spacer on the interaction of beta-galactoside-binding proteins with immobilized affinity ligands. , 1990, Analytical biochemistry.

[103]  R. Kiss,et al.  Galectin‐1 Modulates Human Glioblastoma Cell Migration into the Brain Through Modifications to the Actin Cytoskeleton and Levels of Expression of Small GTPases , 2002, Journal of neuropathology and experimental neurology.

[104]  N. Taniguchi,et al.  Expression of N-Acetylglucosaminyltransferase V Is Associated with Prognosis and Histology in Non-Small Cell Lung Cancers , 2004, Clinical Cancer Research.

[105]  Roger A. Laine,et al.  The Information‐Storing Potential of the Sugar Code , 2008 .

[106]  Hans-Joachim Gabius,et al.  Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. , 2006, Critical reviews in immunology.

[107]  I. Goldstein,et al.  Carbohydrate binding properties of complex-type oligosaccharides on immobilized Datura stramonium lectin. , 1987, The Journal of biological chemistry.

[108]  T. Sato,et al.  Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines. , 2000, Biochemical and biophysical research communications.

[109]  H. Gabius,et al.  Glycomic profiling of developmental changes in bovine testis by lectin histochemistry and further analysis of the most prominent alteration on the level of the glycoproteome by lectin blotting and lectin affinity chromatography. , 2004, Histology and histopathology.

[110]  R. Kiss,et al.  Galectin‐1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma , 2001, Glia.

[111]  H. Gabius,et al.  Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. , 2005, Biochemistry.

[112]  Y. Kloog,et al.  Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.

[113]  B. Wiedenmann,et al.  Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis. , 2002, Journal of the National Cancer Institute.